Used in the dilution of 1:250 in CAS block. Good antibody.
For more information see Hajaj et al. eLife 2020, “SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint”. https://elifesciences.org/articles/52539
On July 12, 2020 Emma Hajaj, Hebrew University of Jerusalem wrote:
Used in the dilution of 1:250 in CAS block. Good antibody.
For more information see Hajaj et al. eLife 2020, “SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint”.
https://elifesciences.org/articles/52539